Motivated To Lead Podcast - Mark Klingsheim

This week, we revisit our conversation with Keith Grossman. Keith has been a leader in the medical technology industry for more than 35 years. He was the Chairman of the Board of Nevro Corporation (NVRO) until April 2025, having previously served as President and CEO from 2019 to April 2023.  Prior to Nevro, he was named President and CEO of Thoratec Corp. (THOR) for the second time in 2014. He led the company's return to growth, a 2.5x increase in company value, and its $3.4 billion acquisition by St. Jude Medical in 2015. He previously served as the CEO, President, and Director of Conceptus, Inc. (CPTS) from 2011 to 2013, where he took the company from negative sales growth to over 20% growth, tripled EBIDTA, and led the company's sale to Bayer Healthcare for over $1.1 billion, a 3x increase in the company's value before his arrival.  Prior to Conceptus, Keith served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Gro